This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Browse our events, training, articles and people by topicclose

Popular sectors

A - Z

Browse Topicsappsclose
search

Peptides & Oligonucleotides

Accelerate oligonucleotide and peptide products from early discovery to late-stage development & commercialization.

Events

Showing 4 of 6 eventsView all events

mRNA Applications in Discovery & Development

November 30 - December 2, Delivered in Eastern Standard Time (EST)

Industry Leaders & Service Providers will showcase the power and diversity of mRNA technologies and applications across discovery, R&D, manufacturing & delivery

TIDES USA: Oligonucleotide & Peptide Therapeutics

Mark Your Calendar for Next Year's Event!, Hynes Convention Center, Boston

Industry’s Largest & Most Renowned Event to Accelerate Your Therapeutics to Market: Leading Strategies for Expediting R&D and Improving CMC Efficiency

TIDES Digital Week: Oligonucleotide & Peptide Therapeutics

May 2022

Industry leaders & service providers uncover leading strategies for expediting R&D and improving CMC efficiency

Introduction to Analytical Control Strategies for Therapeutic Oligonucleotides

September 14 -16, 2021, Online Training Course

LEARN HOW TO DEVELOP AN EVOLVING ANALYTICAL CONTROL STRATEGY FOR YOUR OLIGONUCLEOTIDE DRUG SUBSTANCE

Articles & Video

Showing 9 of 71 articles & videoView all articles & video
Featured
Drug Manufacturing

eBook: Commercial-scale Production of mRNA and Oligonucleotides

We look at strategies for rapid deployment of mRNA manufacturing, oligonucleotide synthesis, navigating regulatory guidance and scaling up.

Featured
Peptides and Oligonucleotides

Report: Oligonucleotide, Peptide, mRNA and Genome Edited Therapeutics State of the Industry 2021

How has the oligonucleotide, peptide, mRNA and genome editing sector transformed over the last year? This industry report provides insight.

Monthly Newsletter

Keep up to date with content on Peptide & Oligonucleotide Therapeutics

Keep up to speed every month with top content on peptide, oligonucleotide and mRNA therapeutics.

Analytical Chemistry

Analytical Strategies for Oligonucleotide and Peptide Therapeutics - TIDES eBook Series

This TIDES eBook focuses on the challenges, strategies and technologies for measuring quality of oligonucleotides and peptides in therapeutic development.

Antisense Oligonucleotides

Chemical Modification of LNA-based Antisense Oligonucleotides

Oligonucleotides

Oligonucleotide scale-up and the impact of equipment with Asahi Kasei Bioprocess America

Sustainability

Sustainability in peptide and oligonucleotide manufacturing: An interview with Aspen API

Oligonucleotides

Improve Oligonucleotide Synthesis Efficiency and Sustainability

Oligonucleotides

Mobile Phase Optimization for the Analysis of Synthetic Oligonucleotides by Ion-Pair Reversed Phase Liquid Chromatography

SPONSORSHIP & EXHIBITION OPPORTUNITIES

There are many ways for your organisation to engage a qualified audience of 40,000+ TIDES executives and scientists, including 2,000+ annual attendees gathered across the globe! Share your strategy and plans so we can help you identify the best opportunities to reach your objectives. Our team will collaborate with you to develop a bespoke program tailored to your unique needs.

To find out more, contact Michael Dunnet, Head of Portfolio Sales:
michael.dunnet@informa.com | +1 (857) 504-6732

All opportunities can be customised to align with your needs and budget. Examples may include:

  • Exhibition space
  • Speaking slots and onsite video interviews
  • High-impact branding and messaging
  • Private/public hosted events (lunches, breakfasts, and receptions)
  • Custom digital campaigns
DOWNLOAD 2020 SPONSOR PROSPECTUS

Copyright © 2021 Informa Connect Limited. Registered in England & Wales with number 01835199, registered office 5 Howick Place, London, SW1P 1WG.